2K
Articles
52.6K
Citations
3.5
avg. Impact Factor
100
h-index

Most Cited Articles of Department of Oncology in 2020

TitleJournalYearCitations
Biomarker-guided therapy for colorectal cancer: strength in complexityNature Reviews Clinical Oncology2020103
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trialLancet Oncology, The202084
Bone health in cancer: ESMO Clinical Practice GuidelinesAnnals of Oncology202082
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable OutcomesCancer Discovery202065
Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolismEPMA Journal202054
Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening ColonoscopiesGastroenterology202054
mutations and disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL studyHaematologica202052
Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-upJAMA Oncology202040
International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemicRadiotherapy and Oncology202040
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma NetworkAnnals of Oncology202039
Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicineEPMA Journal202034
Regulation of gap junction intercellular communication by connexin ubiquitination: physiological and pathophysiological implicationsCellular and Molecular Life Sciences202034
PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trialBMC Cancer202033
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic HeterogeneityClinical Cancer Research202030
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary PeritoneumJournal of Clinical Oncology202029
Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphomaBlood Advances202028
Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition With Pembrolizumab Outcomes in Advanced Melanoma: Pooled Analysis of 3 Clinical TrialsJAMA Oncology202027
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman diseaseBlood Advances202024
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP studyBone Marrow Transplantation202023
Symptom cluster of pain, fatigue, and psychological distress in breast cancer survivors: prevalence and characteristicsBreast Cancer Research and Treatment202023
Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary AdenocarcinomaAnnals of Surgery202023
Encorafenib plus cetuximab with or without binimetinib for BRAF V600E metastatic colorectal cancer: Updated survival results from a randomized, three-arm, phase III study versus choice of either irinotecan or FOLFIRI plus cetuximab (BEACON CRC).Journal of Clinical Oncology202022
Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study)Lung Cancer202021
M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapyBritish Journal of Haematology202021
Liver transplantation for unresectable colorectal liver metastases in patients and donors with extended criteria (SECA-II arm D study)BJS Open202020